semaglutide vision loss Could drugs for diabetes, obesity affect eyesight? Semaglutide Eye Damage | Ozempic

1 Complications include kidney failure, nontraumatic lower-extremity amputation, blindness, heart disease, and stroke

Researchers have also been investigating how the drug, and other GLP-1 drugs, could be used to treat obesity-related comorbidities, like cardiovascular disease and heart failure

Are Peptides the Same as GLP-1 Treatments

Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior weight loss and expanded therapeutic applications spanning from brain health to renal disease". Lillys Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade Davy James Key Takeaways Eli Lilly's orforglipron and retatrutide are pivotal in the cardiometabolic market, with significant sales projections by 2031

However, pharmacokinetic clearance and symptomatic resolution are not identical

Individual outcomes depend on dosage, adherence, metabolic response, and lifestyle factors